Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4744335
Max Phase: Preclinical
Molecular Formula: C29H16ClN7Na4O14S4
Molecular Weight: 854.24
Molecule Type: Unknown
Associated Items:
ID: ALA4744335
Max Phase: Preclinical
Molecular Formula: C29H16ClN7Na4O14S4
Molecular Weight: 854.24
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Nc1c(S(=O)(=O)[O-])cc(Nc2ccc(Nc3nc(Cl)nc(Nc4ccc(S(=O)(=O)[O-])c(S(=O)(=O)[O-])c4)n3)c(S(=O)(=O)[O-])c2)c2c1C(=O)c1ccccc1C2=O.[Na+].[Na+].[Na+].[Na+]
Standard InChI: InChI=1S/C29H20ClN7O14S4.4Na/c30-27-35-28(33-13-6-8-18(52(40,41)42)20(10-13)54(46,47)48)37-29(36-27)34-16-7-5-12(9-19(16)53(43,44)45)32-17-11-21(55(49,50)51)24(31)23-22(17)25(38)14-3-1-2-4-15(14)26(23)39;;;;/h1-11,32H,31H2,(H,40,41,42)(H,43,44,45)(H,46,47,48)(H,49,50,51)(H2,33,34,35,36,37);;;;/q;4*+1/p-4
Standard InChI Key: PGJDRJZEWPXQFL-UHFFFAOYSA-J
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 854.24 | Molecular Weight (Monoisotopic): 852.9640 | AlogP: 3.10 | #Rotatable Bonds: 10 |
Polar Surface Area: 352.40 | Molecular Species: ACID | HBA: 17 | HBD: 8 |
#RO5 Violations: 3 | HBA (Lipinski): 21 | HBD (Lipinski): 9 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: -4.44 | CX Basic pKa: 1.05 | CX LogP: -3.85 | CX LogD: -4.27 |
Aromatic Rings: 5 | Heavy Atoms: 55 | QED Weighted: 0.07 | Np Likeness Score: -0.46 |
1. Jeffrey JL,Lawson KV,Powers JP. (2020) Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ectonucleotidases CD73 and CD39., 63 (22): [PMID:32786396] [10.1021/acs.jmedchem.0c01044] |
Source(1):